| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Peter Svennilson last filed a Form 4 in June 2021, as Director, 10% Owner at ORIC. The filings on record cover 3 companies. Peter Svennilson's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Peter Svennilson a strong insider score of 83/100, based on 8 past trades. Over a 12-month horizon, all 8 of those trades were profitable, with an average 12-month return of +45.2%.
At the last filing, the largest reported position was 1,775,236 shares of RVMD. The RVMD filings lean toward selling, a net 2,260,163 shares.
Peter Svennilson has 14 Form 4 filings on record from April 2020 to June 2021, across 3 companies: Director, 10% Owner at Oric Pharmaceuticals (ORIC), 2020–2021; Director, 10% Owner at RAPT Therapeutics (RAPT), 2020–2021; Director at Revolution Medicines (RVMD), 2020–2021.
The 38 reported transactions were 20 open-market sales, 7 other transactions, 6 option or other derivative awards and 4 conversions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $115.2M.
The largest open-market sale was 2,027,156 shares of RVMD at an average $36.40 on November 16, 2020, about $73.8M.
Shares as reported in the last Form 4 for each company; the most recent is from June 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2021 | RVMD Revolution Medicines, Inc. | Director | Sell | 76,410 | $42.79 | $3,269,345.20 | -4.1% | -17.1% | -37.0% | |
| Apr 9, 2021 | RVMD Revolution Medicines, Inc. | Director | Sell | 70,929 | $44.46 | $3,153,745.02 | -3.8% | -25.6% | -42.6% | |
| Apr 7, 2021 | RVMD Revolution Medicines, Inc. | Director | Sell | 85,668 | $46.96 | $4,023,040.87 | -4.4% | -30.6% | -43.6% | |
| Nov 16, 2020 | RVMD Revolution Medicines, Inc. | Director, 10% Owner | Sell | 2,027,156 | $36.40 | $73,788,478.40 | -45.5% | - | - | |
| Sep 22, 2020 | RAPT Rapt Therapeutics, Inc. | Director, 10% Owner | Sell | 608,000 | $30.85 | $18,756,800.00 | -13.7% | - | - | |
| Aug 17, 2020 | RAPT Rapt Therapeutics, Inc. | Director, 10% Owner | Sell | 538,654 | $22.75 | $12,254,378.50 | -10.8% | - | - |